Skip to main content

Table 1 Comparison of clinical variables between anthracycline and control groups

From: Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines

Variable Anthracycline (n = 18) Control (n = 17) p value
Age (years) 57.6 ± 14.6 48.1 ± 12.2 0.047
Male (n, %) 14 (77) 8 (47) 0.601
Height (cm) 168.2 ± 10.2 164.1 ± 8.5 0.206
Weight (kg) 76.1 ± 15.3 69.7 ± 10.0 0.160
BMI (kg/m2) 26.8 ± 4.3 25.9 ± 2.9 0.469
BSA (m2) 1.86 ± 0.22 1.76 ± 0.15 0.157
Heart rate (bpm) 68.7 ± 14.3 66.2 ± 14.8 0.610
Blood hematocrit (%) 44.6 ± 3.7 44.2 ± 3.6 0.802
SBP (mmHg) 117.2 ± 13.4 120.5 ± 7.5 0.367
DBP (mmHg) 74.1 ± 8.4 76.9 ± 5.8 0.255
Smoking (n, %) 1 (5) 0 (0) 1.000
Hypertension (n, %) 5 (27) 4 (23) 1.000
Diabetes (n, %) 2 (11) 1 (5) 1.000
Dyslipidemia (n, %) 1 (5) 0 (0) 1.000
Framingham risk score (%) 7.8 ± 7.0 3.8 ± 6.6 0.099
  1. Data expressed as mean ± standard deviation (SD) or n (%)
  2. BMI body mass index, BSA body surface area, SBP systolic blood pressure, DBP diastolic blood pressures